Acute toxicity determination of “Latiron” medicinal form
Keywords:acute toxicity, tablets form of complex BAS from Latyrus sativus, aymalin, alapinine
Topicality. Medical plants since olden times attracted attention for researchers by curative properties of its bioactive substances. Searching and creation of medicinal preparations of plant origin is one of the major tasks of pharmaceutical science. From data of folk medicine sowing is different characteristics, and one of them – anti-arrhythmic. By the previous researches conducted on the department of physiology of NUPH perspective of the use of medicinal form “Latiron” was well-proven.
Aim. The aim of this research was experimental study of acute toxicity of the medicinal form “Latiron” in tablets. Materials and methods. The acute toxicity of the medicinal form “Latiron” in tablets had been studied in experimental on two types of laboratory animal: mice and rats at two ways of introduction: intragastric and intraperitoneal. Connections entered as water solutions. Results and discussion. The analysis of results testifies that the medium-lethal dose of preparation at intraperitoneal introduction for mice makes 3740 mg/kg, and for rats 2310 mg/kg, intragastric introduction to ”Latiron” mice in doses a from 4000 to 6000 mg/kg, a from 6000 to 11000 mg/kg of body weight allowed rats to set that LD50, for mice makes 4870 mg/kg, for rats 1948 mg/kg. Watching animals was conducted during 3-th days. At comparison of acute toxicity of “Latiron” and preparations of comparison of “Latiron” in 3.8 times less toxic than aymalin and in 4.6 times – of alapinine. Conclusions. Summarizing the got results, it is possible to draw conclusion, that “Latiron” for K. K. Sidorov`s classification has been proven to belong to practically non-toxic substances. “Latiron” is less toxic than aymalin in 3.8 times, and alapinine in 4.6 times. The therapeutic index of ”Latiron”, which characterizes the therapeutic action range, is greater in 6.4 times that the one of aymalin in 9.4 times than the index of alapinine.
Graefe, E. U., Veit, M. (1999). Urinary metabolites of flavonoids and hydroxycinnamic acids in humans after application of a crude extract from
Equisetum arvense. Phytomedicine, 6 (4), 239–246. doi: 10.1016/s0944–7113(99)80015–4
Weiss, R. F., Fintelmann, V. (2000). Herbal Medicine. Stuttgart. New York: Thieme, 438.
Stefanov, O. V. (2001). Doklinichi doslidzhennia likarskykh zasobiv. Kyiv: Аvіtsеnа, 528.
Trakhtenberg, I. M., Sova, R. E., Sheftel, V. O., Оnikeenko, F. А. (1978). Pokazateli normy u laboratornykh zhivotnykh v toksikologicheskom eksperimente.
Мoscow: Меditsina, 175.
Shtabskii, B. M., Gzhegotskii, М. I., Gzhegotskii, М. R. (1980). Gigiena i sanitaria, 10, 49 – 51.
Efentakis, M., Dressman, J. B. (1998). Gastric juice as a dissolution medium: Surface tension and pH. European Journal of Drug Metabolism and
Pharmacokinetics, 23 (2), 97–102. doi: 10.1007/bf03189322
Hep, A., Pospisilova, J., Dolina, J. et al. (1988). Vnutr. Lek., 44 (7), 396 – 399.
Krantis, A., Glasgow, I., McKay, A. E., Mattar, K., Johnson, F. (1996). A method for simultaneous recording and assessment of gut contractions and
relaxations in vivo. Canadian Journal of Physiology and Pharmacology, 74 (8), 894–903. doi: 10.1139/y96–087
Porter, S. N., Howarth, G. S., Butler, R. N. (2000). Non–steroidal anti–inflammatory drugs and apoptosis in the gastrointestinal tract: potential role
of the pentose phosphate pathways. European Journal of Pharmacology, 397 (1), 1–9. doi: 10.1016/s0014–2999(00)00237–5
Rastogi, L., Patnaik, G. K., Dikshit, M. (1998). Free radicals and antioxidant status following pylorus ligation induced gastric mucosal injury in rats.
Pharmacological Research, 38 (2), 125–132. doi: 10.1006/phrs.1998.0343
Takeuchi, K., Okada, M., Niida, H., Okabe, S. (1999). J. of Pharmacol. And Exp. Therapeutics, 248 (2), 836 – 841.
Whelton, A. (1995). Renal Effects of Over–the–Counter Analgesics. The Journal of Clinical Pharmacology, 35 (5), 454–463. doi: 10.1002/j.1552–
Sidorov, K. K. (1973). Toksikologiia novykh promyshlennykh khimicheskikh veshchestv. Мoscow: Мeditcina,13, 47 – 51.
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).